Related Experiment Video

Updated: Apr 6, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

10.0K

MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game

Zheng Li1, Xin Yu1, Jianxiong Shen1

  • 1Department of Orthopaedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100007, China.

Cell Proliferation
|July 24, 2015
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in rhabdomyosarcoma (RMS) development and metastasis. Understanding miRNA deregulation offers new diagnostic and therapeutic strategies for this common childhood cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Rhabdomyosarcoma (RMS) is a prevalent soft tissue sarcoma in children and young adults, associated with significant morbidity.
  • The precise molecular mechanisms driving RMS initiation, progression, and metastasis are not fully elucidated.
  • MicroRNAs (miRNAs), small non-coding RNAs, regulate gene expression and are increasingly recognized for their roles in cancer.

Purpose of the Study:

  • To review the deregulation and functional significance of miRNAs in RMS.
  • To explore the potential of miRNAs as biomarkers for RMS diagnosis and prognosis.
  • To discuss the therapeutic implications of targeting miRNAs in RMS management.

Main Methods:

  • Literature review of studies investigating miRNA expression and function in Rhabdomyosarcoma.
  • Analysis of the role of specific miRNAs in RMS pathogenesis, including initiation, proliferation, and metastasis.
  • Evaluation of current and emerging applications of miRNAs in RMS diagnostics and therapeutics.

Main Results:

  • Evidence indicates widespread miRNA deregulation in RMS, impacting key cellular processes.
  • Specific miRNAs are associated with RMS subtypes, progression, and metastatic potential.
  • miRNAs show promise as sensitive and specific biomarkers for early detection and prognosis.

Conclusions:

  • miRNA deregulation is a critical factor in Rhabdomyosarcoma development and progression.
  • Targeting miRNAs presents a promising avenue for novel therapeutic strategies against RMS.
  • Further research into miRNA mechanisms will enhance RMS management and patient outcomes.

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.2K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

3.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K